Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Minoxidil

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Menu

    NCGC00024666-03

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 87Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Veradermics Secures $150M For VDPHL01 Phase 3 Trials In Hair
    Veradermics Secures $150M For VDPHL01 Phase 3 Trials In Hair

    16 Oct 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251016863981/en/Veradermics-Announces-Oversubscribed-%24150-Million-Series-C-Financing-to-Advance-VDPHL01-Through-Multiple-Phase-3-Trials-as-Potentially-the-First-Non-Hormonal-Oral-Therapeutic-for-Hair-Regrowth-in-Women-and-Men

    BUSINESS WIRE
    16 Oct 2025
    Share Share
    1st Patient Randomized in Samson Ph 3 Sublingual Minoxidil Trial
    1st Patient Randomized in Samson Ph 3 Sublingual Minoxidil Trial

    07 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/first-patient-randomised-in-samson-clinical-phase-iii-sublingual-minoxidil-trial-for-male-pattern-hair-loss-androgenetic-alopecia-302523124.html

    PR NEWSWIRE
    07 Aug 2025
    Share Share
    Eirion Therapeutics to present at 2025 AAD Innovation Academy
    Eirion Therapeutics to present at 2025 AAD Innovation Academy

    09 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eirion-therapeutics-to-present-at-the-2025-american-academy-of-dermatology-innovation-academy-meeting-302492376.html

    PR NEWSWIRE
    09 Jul 2025
    Share Share
    Taro’s Generics Minoxidil Extra Strength Approved in US
    Taro’s Generics Minoxidil Extra Strength Approved in US

    30 Jun 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217998

    FDA
    30 Jun 2025
    Share Share
    Second U.S. Patent Issued for Safety Shot™s JW-700
    Second U.S. Patent Issued for Safety Shot™s JW-700

    25 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/25/2766493/0/en/Second-U-S-Patent-Issued-for-Safety-Shot-s-JW-700-Which-Boosts-Effectiveness-of-Minoxidil-Rogaine-in-1-5-Billion-Hair-Growth-Market.html

    GLOBENEWSWIRE
    25 Oct 2023
    Share Share
    Hyundai Pharm accidentally labels hypertension drug as dementia treatmen
    Hyundai Pharm accidentally labels hypertension drug as dementia treatmen

    01 Jul 2023

    // KOREA BIOMED

    https://www.koreabiomed.com/news/articleView.html?idxno=21486

    KOREA BIOMED
    01 Jul 2023
    Share Share